MDT vs STRO · P/E 21, rev $36.36B vs rev $62.0M
Medtronic PLC (MDT) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Medtronic PLC (MDT) is a medical devices company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
MDT currently screens at market cap $100.08B and trailing P/E 20.9. STRO currently screens at market cap $470.8M.
Not investment advice. Open the MDT and STRO stock pages for the full models.
Not investment advice.